Sep 30, 2021

Nurosene Adds NHL Star James van Riemsdyk to its Mental Health Advisory Council

Welcome aboard! Your submission has been received and you are now a member of the community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
Subscribe to Excellence

Van Riesmdyk will serve as an advisor to help drive awareness around mental health, while facilitating the company's mission to make brain health solutions accessible for all.

TORONTO, Sept. 30, 2021 /CNW/ - Nurosene Health Inc. ("Nurosene" or the "Company") (CSE: MEND) (Frankfurt: 8TV) (OTC: MNNDF), a healthtech company focused on building a generation of better brains, today announced that it has added National Hockey League player  James van Riemsdyk to Nurosene's Mental Health Advisory Council. In this role, van Riemsdyk will serve as an advocate and champion bringing awareness to brain and mental health and help further the company's mission to make brain health tools accessible for all, particularly young American's playing hockey.

"We are excited to welcome James to our Nurosene Community as he brings incredible passion and insight to the many issues that must be addressed related to mental and brain health. Additionally, James, a leader and trailblazer in the hockey world, will bring a unique perspective based upon his personal experiences from hockey where there is a high frequency of high speed collisions.  These insights will be powerful in helping transform how brain health is perceived and prioritized, in sport."  
~ Ranj Bath, CEO of Nurosene

Van Riemsdyk is currently a left winger for the NHL's Philadelphia Flyers and previously played in the NHL for the Toronto Maple Leafs.

"I am excited to join Nurosene's Mental Health Advisory Council to drive awareness and reinforce the importance of prioritizing brain health, as it is core to our overall mental and physical well-being as humans. As a professional hockey player, brain health has become increasingly prevalent as many in the sports industry, myself included, have felt an impact from concussions or other injuries that can greatly affect one's overall mental wellness. Nurosene's advanced technology and overall mission focusing on brain health is a huge step toward bridging these mental and physical health gaps."
~ van Riemsdyk, left winger for the NHL's Philadelphia Flyers

Van Riemsdyk is originally from New Jersey, where he grew up playing hockey for local clubs. In 2007 he was drafted to the Flyers, played college ice hockey for the University of New Hampshire, and then made his NHL debut in 2009 with the Philadelphia professional team and was notably played for the Toronto Maple Leafs. In addition to his NHL career, van Riemsdyk proudly represented the United States at the 2014 Winter Olympics.

About Nurosene

Nurosene provides individuals with tools and technology that empower them to take control of their mental wellness. Our mission is to build the next generation of better, healthier brains by leveraging technological advancements in AI and machine learning. With our team of experts and partners, Nurosene is positioned at the leading edge of critical research and innovations, striving to disrupt traditional mental wellness treatments.

For more information, visit

Forward-Looking Statements

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation which is based upon Nurosene's current internal expectations, estimates, projections, assumptions and beliefs, and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. Specifically, this news release contains forward-looking information relating to the work of the Company's Mental Health Advisory council.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Nurosene does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Nurosene to predict all such factors. When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in Nurosene Final Long Form Prospectus dated May 20, 2021 and filed with the applicable Canadian securities regulatory authorities on SEDAR at The risk factors and other factors noted in Nurosene Final Long Form Prospectus could cause actual events or results to differ materially from those described in any forward-looking information.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Nurosene Health Inc.

View original content to download multimedia:


The work included in this article is based on current events, technical charts, company news releases, and the author’s opinions. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. This publication contains forward-looking statements, including but not limited to comments regarding predictions and projections. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. This publication is provided for informational and entertainment purposes only and is not a recommendation to buy or sell any security. Always thoroughly do your own due diligence and talk to a licensed investment adviser prior to making any investment decisions. Junior resource and biotechnology companies can easily lose 100% of their value so read company profiles on for important risk disclosures. It’s your money and your responsibility.